Cite
HARVARD Citation
Viviani, S. et al. (2020). Early serum TARC reduction predicts prognosis in advanced‐stage Hodgkin lymphoma patients treated with a PET‐adapted strategy. Hematological oncology. 38 (4), pp. 501-508. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Viviani, S. et al. (2020). Early serum TARC reduction predicts prognosis in advanced‐stage Hodgkin lymphoma patients treated with a PET‐adapted strategy. Hematological oncology. 38 (4), pp. 501-508. [Online].